Modern Traditional Chinese Medicine

Pre Next

Copy

Modern Traditional Chinese Medicine[ISSN: 1006-6977/ CN: 61-1281/TN] Volumes & Issues: 2021 03 pagination: 47-54 Column: Publication date: 2021-05-20

Article number:: 1672-0571(2021)03-0047-08

ZTFLH:: 917

DOI:: 10.13424/j.cnki.mtcm.2021.03.010

Code:: A

References:

[1]YehhyLiul.Cholesterol-loweringeffectorofgarlicextractsandorgansourcompounds:humanandanimalstudies[J].JNutr,2001,131(Suppl3):989-993.
[2]Milnerja.Garlicitsanticarcinorganicandantitumor!genicproperties[J].NutrRev,2009,54(11):82-86.
[3]IdenLaubhs.GarliccompoundsminimizeintracellularoxidativestressandinhibitnuclearfactorKBactivation[J].JNutr,2001,131(35):1020-1026.
[4]ZuY,ZhaoQ,ZhaoX,eta1.Processoptimizationforthepreparationofoligomycin-loadedfolate-conjugatedchitosannanoparticlesasatumor-targeteddrugdeliverysystemusingatwo-levelfactorialdesignmethod[J].IntJNanomedicine,2011,(6):3429-3441.
[5]ChenF,TanJ,YangXJ.Applicationsofchitosananditsderivatives[J].JSouthwestUniversityforNationalities?NaturalScienceEdition,2002,28(1):40-44.
[6]SchipperNGM,VarumKM,StenbergP,etal.Chitosanasabsorptionenhencersforpoorlyabsorbabledrugs3:Influenceofmucusonabsorptionenhancement[J].EurJPharmSci,1999,8(4):335-343.
[7]郝英魁,杨学东.载药壳聚糖纳米粒的研究进展[J].中国药学杂志.2005,40(17):1292-1295.
[8]Tommeraask,Koping-HoqqardM,Varumkm,etal.Preparationandcharacterizationofchitosanswitholigosaccharidebranches[J].CarbhydrateRes,2002,337(24):2455 2462.
[9]WeinerM.Anoverviewoftheregulatorystatusandofthesafetyofchitinandchitosanasfoodandpharmaceuticalingredients[M].BrineCJ,SandfordPA,XikakisJP.AdvancedChitinandChitosan.London:ElsevierAppliedScience,1992:663-670.
[10]UbonvanT,HyunJC,DongHW,eta1.Chitosanoligosaccharide- arachidicacid-basednanoparticlesoranti-cancerdrugdelivery[J].IntJPharmaceutics,2013,441(1-2):373-380.
[11]黄佩文,苏萍,魏晓红,等.壳寡糖/水杨酸接枝物纳米粒用于释放阿霉素的研究[J].中国现代应用药学,2014,31(1):61-66.
[12]JanesKA,CalvoP,AlonsoMJ.Polysaccharidecoloidalparticlesasdeliverysystemsformacromolceules[J].AdvDrugDelivRev,2001,47(1):83-97.
[13]JanesKA,FresneauMP,MarazuelaA,etal.Chitosannanoparticlesasdeliverysystemsfordoxonrbiein[J].JControlledRelease,2001,73(2-3):255-267.
[14]MaddenTD,HarriganPR.TaiLCL.etal.Theaccumulationofdrugswithinlargeunilamellarvesiclesexhibitingaprotongradient:asurvey.Chem.pHys.Lipids,1990,53(1):37-46.
[15]杜松,邓英杰.氧化苦参碱脂质体的研究[D].沈阳:沈阳药科大学,2005:6365.
[16]CalvoP,Remunan-LopezC.,Vila-JatoJ.L.,eaal.NovelHydrophilicchitosan-polyethyleneoxidenanoparticlesasproteincarriers.J.APPI.Polym.Sci,1997,63(1):125?132.
[17]MaoHai-quan,KrishnenduRoy,etal.Chitosan-DNAnanoparticlesasgenecarriers:synthesis,characterizationandtransfectionefficiencyJ.Control.Rel.,2001, 70(3):399-421.
[18]谢振.低分子量壳聚糖纳米粒的制备及其对三七点皂苷肠道渗透性的影响[J].江西:江西师范大学,2020.
[19]BegonaCG,RuthD.Evaluationofthebiologicalpropertiesofsolublechitosanandchitosanmicrospheres[J].IntJPharm,1997,148(2):231-240.
[20]徐咏梅,杜予民.低分子量壳聚糖纳米粒子缓释蛋白质药物性能的研究 [J].武汉大学学报 (理学版),2003,49(4):470-474

Last Update: 2021-06-08